Sanara MedTech(US:SMTI) Globenewswire·2025-10-01 11:30Core Viewpoint - Sanara MedTech Inc. is set to report its third quarter 2025 financial results on November 12, 2025, before U.S. markets open, indicating ongoing transparency and communication with investors [1]. Company Overview - Sanara MedTech Inc. focuses on developing and commercializing transformative technologies aimed at improving clinical outcomes and reducing healthcare costs in surgical, chronic wound, and skin markets [4]. - The company markets and distributes a range of surgical, wound, and skin products primarily in the North American advanced wound care and surgical tissue repair markets [4]. - Key products include CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft, and various advanced biologic products [4]. - Sanara's pipeline includes product candidates targeting opportunistic pathogens, wound healing, and necrotic tissue debridement, showcasing its commitment to innovation [4]. Upcoming Events - A conference call and webcast will be held on November 12, 2025, at 8:00 a.m. Eastern Time to discuss the financial results and engage in a Q&A session [2]. - The conference call can be accessed via a toll-free number, with a replay available until November 26, 2025 [2]. Investor Relations - Investor relations contacts are provided for further inquiries, indicating the company's openness to communication with stakeholders [7].